u/marit_sandvik

a fifteen-residue peptide is easy to make and easy to make badly

A private prescription is an independent route: it does not affect NHS list position, and it is not a step in the same pathway.

Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.

SURMOUNT-1 landed around 21% at 72 weeks on the top arm

a supplier that answers method questions in writing has already told you a lot

Stopped for financial reasons and regained most of it. Not a moral story, just a budget and a documented outcome.

rigid outer packaging is the cheapest quality signal there is

this board exists so the failures are on the record too

Did you ask for the batch-specific certificate, or the generic one?

Where a supplier holds regional stock, ask which lines are actually held there rather than drop-shipped. It changes the lead time and it changes the customs question.

Purity by area percent tells you the sample is homogeneous. Mass spectrometry tells you what the homogeneous thing is. For a short peptide, the second question is the one worth paying for.

2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.

oral semaglutide is a peptide with an absorption enhancer, this is not that

Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.

Was there a point where the information was available and you did not look?

Small correction — the shop in that story has no independent testing on file at all, which is different from having a bad record.

Six orders across two years from MKM. Same packaging, same paperwork, same lead time. The most boring supplier relationship I have and I mean that as praise.

a claim with no batch number is a marketing document

I would not read a supply notice as a shortage in your pharmacy tomorrow. They are not the same thing.

This matches mine. Milder constipation than I expected, and what there was settled inside a fortnight of each step.

Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.

Correction to my own post above — I said 15mg and I have been on 2.5mg since the spring.

This. The step interval is a floor, and reading it as a timetable is the most expensive mistake in the thread.

It is a non-peptide small-molecule agonist at the GLP-1 receptor. That is a substantial medicinal chemistry achievement: getting a small molecule to activate a receptor evolved for a peptide ligand.

Because it is not a peptide, it is not subject to the same degradation pathways, does not require the absorption enhancers used for oral peptides, and can be formulated as a conventional tablet.

Accused the wrong party publicly and it was my storage. Correcting it here was the most uncomfortable post I have made and the right one.

That is Scotland’s arrangement and the post is asking about England.

Where a supplier holds regional stock, ask which lines are actually held there rather than drop-shipped. It changes the lead time and it changes the customs question.

A certificate with a purity figure and no method line is not falsifiable. You cannot reproduce it, you cannot check it, and it tells you nothing about how the number was produced.

this board exists so the failures are on the record too

Where a supplier holds regional stock, ask which lines are actually held there rather than drop-shipped. It changes the lead time and it changes the customs question.

What did the tolerability table look like at that dose?

Correcting myself: that was a phase 2 readout and I described it as phase 3.

I would not assume the tolerability profile transfers exactly.

Disagreeing with this bit: daily dosing is a different adherence problem, not a better one.

Careful with naming anybody. The board rule holds even here, and especially here.

Correction to my own post: it was my storage, not the shipment. Leaving the original up with this attached.

In England, specialist weight management services are commissioned locally, so eligibility criteria and waiting times differ by ICB. There is no single national threshold to quote.

What do you want from posting it — advice, or just to have it on the record?

Yes. Spread across lots is the number that tells you about the process. A single high result tells you about a vial.

a lane with four reports is not yet a lane

a directory entry is a record, not a recommendation